Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Grant or award Director acquired 2,831 shares (grant or award)
  2. 4 Open-market buy President & CFO bought 12,385 shares at $1.35 ($16,681)
  3. 4 Open-market buy President & CFO bought 81,000 shares at $1.24 ($100,173)
  4. 4 Grant or award Director acquired 2,277 shares (grant or award)
  5. 4 Grant or award Director acquired 2,086 shares (grant or award)
  6. 4 Grant or award See Remarks acquired 1,578 shares (grant or award)
  7. 4 Grant or award See Remarks acquired 6,369 shares (grant or award)
  8. 4 Grant or award Chief Accounting Officer acquired 1,574 shares (grant or award)
  9. 4 Grant or award Director acquired 9,026 shares (grant or award)
  10. 4 Grant or award Director acquired 1,597 shares (grant or award)
  11. 4 Grant or award Executive Chair of the Board acquired 40,000 shares (grant or award)
  12. 4 Grant or award Director acquired 10,000 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 10,000 shares (grant or award)
  16. 4 Grant or award Director acquired 11,330 shares (grant or award)
  17. 4 Grant or award Director acquired 10,000 shares (grant or award)
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 33 · 648 filings